Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Condition(s):Solid Tumor; Advanced Breast CancerLast Updated:December 23, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Solid Tumor; Advanced Breast CancerLast Updated:December 23, 2022Withdrawn
Condition(s):Corona Virus InfectionLast Updated:November 29, 2023Completed
Condition(s):Pulmonary Disease Due to Mycobacteria (Diagnosis)Last Updated:August 8, 2023Recruiting
Condition(s):AbscessLast Updated:July 1, 2020Completed
Condition(s):COVID-19Last Updated:May 27, 2020Terminated
Condition(s):Severe Acne VulgarisLast Updated:February 18, 2021Completed
Condition(s):Novel Coronavirus Infectious Disease (COVID-19)Last Updated:February 27, 2020Unknown status
Condition(s):Skin Diseases, InfectiousLast Updated:May 4, 2018Completed
Condition(s):CellulitisLast Updated:August 14, 2012Completed
Condition(s):MalariaLast Updated:August 23, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.